Novel application of ionic liquids as broad-spectrum herbicides or adjuvants that disrupt plant cuticle and cell wall. Derived from low-toxicity, biologically sourced molecules, ionic liquids such as cholinium lysinate offer a new mode of action for weed management and potential synergy with existing herbicides.
This research proposes ionic liquids (ILs) as a novel class of herbicides for agricultural weed management. Ionic liquids are salts that remain molten at room temperature and have previously been developed for biomass deconstruction in biofuel production. The researcher's hypothesis is that these same ionic liquids can disrupt the plant cuticle and cell wall of living plants, functioning either as standalone broad-spectrum herbicides or as adjuvants that enhance the effectiveness of existing chemical herbicides at lower application concentrations.
The ionic liquids under investigation are low-toxicity molecules that can be derived from biological sources, making them attractive candidates for sustainable crop protection. Preliminary laboratory tests on Arabidopsis and sorghum seedlings demonstrated wilting and death following surface application of low millimolar concentrations of ionic liquid, with consistent results across three independent trials.
Core technology:
Potential applications:
Research approach:
This technology is at an early research and validation stage. Proof-of-concept has been established through three replicated laboratory experiments on Arabidopsis and sorghum seedlings, demonstrating consistent wilting and mortality at low millimolar concentrations. The research team has now relocated to the University of Adelaide, where collaborators with expertise in weed management and access to dedicated test plot facilities have been engaged. Planned next steps include rigorous field-condition testing on multiple Australian weed species and evaluation of ionic liquid- herbicide combination strategies. Further development will require scaled-up efficacy data, toxicology profiling, formulation optimization, and regulatory assessment before commercial deployment can be considered.
The University of Adelaide was a comprehensive public research university in South Australia, with a city‑centre campus and specialised sites linking teaching, research and translation. Co‑location within Adelaide BioMed City placed teams beside the Royal Adelaide Hospital and SAHMRI, enabling clinical trials, while AIML at Lot Fourteen linked researchers to an innovation district. At the Waite Research Precinct, co‑located partners and infrastructure such as the Plant Accelerator supported industry‑engaged R&D. Research was backed by national funding, including the Australian Research Council and NHMRC. On January 5, 2026 it merged with the University of South Australia to form Adelaide University; these assets now operate within the new institution with dedicated tech transfer support.